Search
for
Sort by
Research 211–240 of 301
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Editor’s Picks June 2025
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Animal models of androgen-dependent disorders of the pilosebaceous apparatus
- A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis
- Serum Iron, Zinc, and Copper Concentration in Premature Graying of Hair
- Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
- Effect of cyclosporin on hair-existing area of nude mice
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Inflammatory auxo-action in the stem cell division theory of cancer
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- A Portable Electrospinner for Nanofiber Synthesis and Its Application for Cosmetic Treatment of Alopecia
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- Exploring novel management options for alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Alopecia in Children
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Phytochemicals and novel delivery systems in alopecia management: An integrative review